A detailed history of Financial Security Advisor, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Financial Security Advisor, Inc. holds 4,207 shares of LLY stock, worth $3.89 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares
4,207
Previous 4,194 0.31%
Holding current value
$3.89 Million
Previous $3.26 Billion 16.74%
% of portfolio
1.28%
Previous 1.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$724.87 - $909.04 $9,423 - $11,817
13 Added 0.31%
4,207 $3.81 Billion
Q1 2024

Apr 18, 2024

BUY
$592.2 - $792.28 $34,347 - $45,952
58 Added 1.4%
4,194 $3.26 Billion
Q4 2023

Jan 24, 2024

SELL
$525.19 - $619.13 $63,022 - $74,295
-120 Reduced 2.82%
4,136 $2.41 Billion
Q3 2023

Nov 08, 2023

BUY
$434.7 - $599.3 $1.85 Million - $2.55 Million
4,256 New
4,256 $2.29 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $878B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Financial Security Advisor, Inc. Portfolio

Follow Financial Security Advisor, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Security Advisor, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Security Advisor, Inc. with notifications on news.